These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343 [TBL] [Abstract][Full Text] [Related]
3. [Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others]. Forst T; Pfützner A Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S268-73. PubMed ID: 17139585 [TBL] [Abstract][Full Text] [Related]
4. Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity. Emanuele E Hepatology; 2008 Dec; 48(6):2086-7; author reply 2087. PubMed ID: 19030167 [No Abstract] [Full Text] [Related]
5. Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A J Dermatol Sci; 2009 Sep; 55(3):202-4. PubMed ID: 19576730 [No Abstract] [Full Text] [Related]
6. Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals. Schäuble CL; Hampel R; Breitner S; Rückerl R; Phipps R; Diaz-Sanchez D; Devlin RB; Carter JD; Soukup J; Silbajoris R; Dailey L; Koenig W; Cyrys J; Geruschkat U; Belcredi P; Kraus U; Peters A; Schneider AE Occup Environ Med; 2012 Sep; 69(9):670-8. PubMed ID: 22833664 [TBL] [Abstract][Full Text] [Related]
7. Relationship between adiponectin, inflammatory markers and obesity in type 2 diabetic and non-diabetic Trinidadians. Nayak S; Soon SQ; Kunjal R; Ramadoo R; Baptiste O; Persad J; Temull V; Diptee L; Balgobin S Arch Physiol Biochem; 2009 Feb; 115(1):28-33. PubMed ID: 19267280 [TBL] [Abstract][Full Text] [Related]
8. Simple steatosis is a more relevant source of serum inflammatory markers than omental adipose tissue. Li Y; Liu L; Wang B; Wang J; Chen D Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):46-54. PubMed ID: 24075193 [TBL] [Abstract][Full Text] [Related]
9. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769 [TBL] [Abstract][Full Text] [Related]
10. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial. de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343 [TBL] [Abstract][Full Text] [Related]
11. Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease. Targher G J Hepatol; 2006 Dec; 45(6):879-81; author reply 881-2. PubMed ID: 17049665 [No Abstract] [Full Text] [Related]
12. [Analysis of the correlation between visceral fat accumulation and the severity of fatty liver in adults]. Liu PJ; Ma F; Lou HP; Du CW; Tao X Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):697-8. PubMed ID: 19785961 [No Abstract] [Full Text] [Related]
13. Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Rizzo M; Berneis K; Spinas G; Rini GB; Carmina E Fertil Steril; 2009 Apr; 91(4 Suppl):1563-7. PubMed ID: 18976752 [TBL] [Abstract][Full Text] [Related]
14. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438 [TBL] [Abstract][Full Text] [Related]
15. Multiple biomarkers for predicting cardiovascular events: lessons learned. Wang TJ J Am Coll Cardiol; 2010 May; 55(19):2092-5. PubMed ID: 20447531 [No Abstract] [Full Text] [Related]
17. Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Varady KA; Tussing L; Bhutani S; Braunschweig CL Metabolism; 2009 Aug; 58(8):1096-101. PubMed ID: 19477470 [TBL] [Abstract][Full Text] [Related]
18. [Emerging risk factors for cardiovascular disease]. Demant T Dtsch Med Wochenschr; 2004 Jan; 129(5):204-9. PubMed ID: 14735418 [No Abstract] [Full Text] [Related]
19. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Chiang CH; Huang CC; Chan WL; Chen JW; Leu HB Clin Biochem; 2010 Dec; 43(18):1399-404. PubMed ID: 20846522 [TBL] [Abstract][Full Text] [Related]
20. Letter by Bell and O'keefe regarding article, "Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease". Bell DS; O'Keefe JH Circulation; 2008 Sep; 118(11):e156; author reply e157. PubMed ID: 18779451 [No Abstract] [Full Text] [Related] [Next] [New Search]